A Data-Driven Computational Model of the ErbB Receptor Signaling Network. - Birgit Schoeberl; Emily Pace; Shavonne Howard; Viara Garantcharova; Art Kudla; Peter K. Sorger; Ulrik B. Nielsen (EMBC, 2006)

Model-based design approaches in drug discovery: A parallel to traditional engineering approaches. - Birgit Schoeberl; Ulrik B. Nielsen; Ricardo Paxson (IBM J. Res. Dev., 2006)

Applications of sensitivity analysis for drug discovery and development in the ErbB receptor network. - Brian Harms; Allen Lee; Ricardo Paxson; Ulrik B. Nielsen; Birgit Schoeberl (BMC Syst. Biol., 2007)

Learning Cyclic Signaling Pathway Structures While Minimizing Data Requirements. - Karen Sachs; Sleiman Itani; J. Fitzgerald; L. Wille; Birgit Schoeberl; Munther A. Dahleh; Garry P. Nolan (Pacific Symposium on Biocomputing, 2009)

Data2Dynamics: a modeling environment tailored to parameter estimation in dynamical systems. - Andreas Raue; Bernhard Steiert; Max Schelker; Clemens Kreutz; Tim Maiwald; Helge Hass; Joep Vanlier; Christian Tönsing; Lorenz Adlung; Raphael Engesser; Wolfgang Mader 002; Tim Heinemann; et al. (Bioinform., 2015)

HER2+ Cancer Cell Dependence on PI3K vs. MAPK Signaling Axes Is Determined by Expression of EGFR, ERBB3 and CDKN1B. - Daniel C. Kirouac; Jinyan Du; Johanna Lahdenranta; Matthew D. Onsum; Ulrik B. Nielsen; Birgit Schoeberl; Charlotte F. McDonagh (PLoS Comput. Biol., 2016)

Ten simple rules to power drug discovery with data science. - Enrico Ferrero; Sophie Brachat; Jeremy L. Jenkins; Philippe Marc; Peter Skewes-Cox; Robert C. Altshuler; Caroline Gubser Keller; Audrey Kauffmann; Erik K. Sassaman; Jason M. Laramie; Birgit Schoeberl; Mark L. Borowsky; et al. (PLoS Comput. Biol., 2020)